Susquehanna International Group’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $202K | Buy |
141,056
+67,274
| +91% | +$96.2K | ﹤0.01% | 5540 |
|
|
2025
Q1 | $118K | Buy |
73,782
+29,559
| +67% | +$47.3K | ﹤0.01% | 5800 |
|
|
2024
Q4 | $159K | Sell |
44,223
-5,884
| -12% | -$21.2K | ﹤0.01% | 5453 |
|
|
2024
Q3 | $286K | Buy |
50,107
+6,077
| +14% | +$34.6K | ﹤0.01% | 4359 |
|
|
2024
Q2 | $203K | Sell |
44,030
-443,621
| -91% | -$2.05M | ﹤0.01% | 4721 |
|
|
2024
Q1 | $3.98M | Sell |
487,651
-514,862
| -51% | -$4.21M | ﹤0.01% | 1187 |
|
|
2023
Q4 | $5.66M | Buy |
1,002,513
+840,650
| +519% | +$4.75M | ﹤0.01% | 1070 |
|
|
2023
Q3 | $301K | Sell |
161,863
-63,329
| -28% | -$118K | ﹤0.01% | 4032 |
|
|
2023
Q2 | $619K | Sell |
225,192
-42,875
| -16% | -$118K | ﹤0.01% | 3344 |
|
|
2023
Q1 | $842K | Buy |
268,067
+252,406
| +1,612% | +$793K | ﹤0.01% | 3141 |
|
|
2022
Q4 | $92.4K | Sell |
15,661
-27,209
| -63% | -$161K | ﹤0.01% | 4984 |
|
|
2022
Q3 | $376K | Buy |
+42,870
| New | +$376K | ﹤0.01% | 3923 |
|
|
2022
Q2 | – | Sell |
-37,520
| Closed | -$910K | – | 5878 |
|
|
2022
Q1 | $910K | Buy |
37,520
+2,691
| +8% | +$65.3K | ﹤0.01% | 2934 |
|
|
2021
Q4 | $1.12M | Sell |
34,829
-8,586
| -20% | -$276K | ﹤0.01% | 2713 |
|
|
2021
Q3 | $1.94M | Buy |
43,415
+19,888
| +85% | +$889K | ﹤0.01% | 1999 |
|
|
2021
Q2 | $890K | Buy |
23,527
+17,255
| +275% | +$653K | ﹤0.01% | 3139 |
|
|
2021
Q1 | $232K | Buy |
+6,272
| New | +$232K | ﹤0.01% | 4632 |
|